{"disease":{"id":"macrophage-activation-syndrome-mas","name":"macrophage activation syndrome mas"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05001737","title":"Evaluate Efficacy, Safety and Tolerability, PK and PD of Emapalumab in Children and Adults With MAS in Still's or SLE","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":33,"lead_sponsor_name":"Swedish Orphan Biovitrum","has_results":true},{"nct_id":"NCT06992505","title":"Assessment of Macrophage Activation syndromE in STill's Disease in Italy","phase":"","overall_status":"COMPLETED","enrollment_count":32,"lead_sponsor_name":"Swedish Orphan Biovitrum","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}